People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xoft Inc | — | Other Health Care | Series A | $12.1M | $16.2M | 2009 |
| Hemosphere, Inc. | — | Biotechnology | Series A | $9.3M | $337.9M | 2010 |
Jonathan Osgood at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Osgood on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tara Butler | 1 | 12 |
| Michael Klein | 1 | 9 |
| John Friedman | 1 | 9 |
| David Singer | 1 | 7 |
| Jeffrey Bird | 1 | 5 |
| David Schulte | 1 | 4 |
| Arda Minocherhomjee | 1 | 4 |
| Paul Farmer | 1 | 3 |
| Edson W. Spencer | 1 | 2 |
| WILLIAM S. TRAINOR | 1 | 2 |
| Kurt Wheeler | 1 | 2 |
| Mhairi Jones | 1 | 1 |
| Thomas Rusch | 1 | 1 |
| Doris S. Engibous | 1 | 1 |
| Susan Horvath | 1 | 1 |
| Mitchell W. Dann | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.